Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Trinity Biotech (TRIB) Share-based Compensation (IS) (2021 - 2024)

Trinity Biotech's Share-based Compensation (IS) history spans 4 years, with the latest figure at $140000.0 for Q4 2024.

  • On a quarterly basis, Share-based Compensation (IS) rose 113.88% to $140000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was -$130750.0, a 111.21% decrease, with the full-year FY2024 number at $1.3 million, down 36.39% from a year prior.
  • Share-based Compensation (IS) hit $140000.0 in Q4 2024 for Trinity Biotech, up from $250.0 in the prior quarter.
  • Over the last five years, Share-based Compensation (IS) for TRIB hit a ceiling of $1.3 million in Q4 2022 and a floor of -$1.0 million in Q4 2023.
  • Historically, Share-based Compensation (IS) has averaged $162298.2 across 4 years, with a median of $119000.0 in 2022.
  • Biggest five-year swings in Share-based Compensation (IS): skyrocketed 755.84% in 2022 and later crashed 176.56% in 2023.
  • Tracing TRIB's Share-based Compensation (IS) over 4 years: stood at $154000.0 in 2021, then skyrocketed by 755.84% to $1.3 million in 2022, then crashed by 176.56% to -$1.0 million in 2023, then surged by 113.88% to $140000.0 in 2024.
  • Business Quant data shows Share-based Compensation (IS) for TRIB at $140000.0 in Q4 2024, $250.0 in Q3 2024, and -$1.0 million in Q4 2023.